News

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...
Maternal deaths increased from 2000 to 2019, with much of the increase attributable to the pregnancy checkbox on death certificates.
Distinct trends were seen in etiology-based mortality with chronic liver disease before, during, and after the COVID-19 pandemic.
Novo Nordisk is collaborating with multiple telehealth organizations in an effort to increase patient access to authentic Wegovy.
Among patients hospitalized with severe gastrointestinal bleeding, there were low rates of diagnosis and treatment of iron deficiency anemia.
The FDA has accepted for review the New Drug Application for a 25mg oral formulation of semaglutide for chronic weight management.
The European Union is looking to capitalize on the Trump administration's dismantling of US research programs to beef up its own.
Michael Rogers, associate commissioner for inspections and investigations at the US FDA, announced his retirement.
Despite a decline in the global burden of pancreatitis between 1990 and 2021, regions like Eastern Europe face a disproportionately high burden of disease.
Early-life mutagenic exposure to colibactin-producing bacteria may be associated with increased incidence of early-onset colorectal cancer.
The FDA has granted Orphan Drug designation to TPST-1495, dual receptor inhibitor of prostaglandin signaling, for the treatment of familial adenomatous polyposis.
Liver disease was associated with reduced protection against influenza-associated hospitalization following influenza vaccination.